semaglutide type 1 diabetes automated insulin delivery randomized trial 2025 GLP-1s and Care: What We Learned at ADA Semaglutide in Adults with Type
Description
doi:10.1136/heartjnl-2019-315859 Elkayam U, Goland S, Pieper PG, Silversides CK
Weight loss from semaglutide persists as long as one remains on the medication
C., Florkowski, C
Ozempic may be more accessible for diabetic patients, while Wegovy provides clearer weight loss indication for non-diabetic individuals
doi: 10.1186/s40168-024-01975-x
Ozempic was FDA-approved for type 2 diabetes in 2017, and Wegovy (a higher dose of semaglutide approved for weight loss) in 2021
